These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6244127)

  • 1. Activation of latent Graves' disease in children. Review of possible psychosomatic mechanisms.
    Morillo E; Gardner LI
    Clin Pediatr (Phila); 1980 Mar; 19(3):160-3. PubMed ID: 6244127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bereavement as an antecedent factor in thyrotoxicosis of childhood: four case studies with survey of possible metabolic pathways.
    Morillo E; Gardner LI
    Psychosom Med; 1979 Nov; 41(7):545-55. PubMed ID: 395558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulins from Graves' patients stimulate phospholipase-A2 in FRTL5 thyroid cells.
    Di Cerbo A; Di Girolamo M; Guardabasso V; De Filippis V; Corda D
    J Clin Endocrinol Metab; 1992 Mar; 74(3):585-92. PubMed ID: 1310998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
    Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
    Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible etiological role of psychological disturbances in Graves' disease.
    Harsch I; Paschke R; Usadel KH
    Acta Med Austriaca; 1992; 19 Suppl 1():62-5. PubMed ID: 1519457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated ACTH deficiency with Graves' disease: a case report.
    Miyauchi S; Yamashita Y; Matsuura B; Onji M
    Endocr J; 2004 Feb; 51(1):115-9. PubMed ID: 15004417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
    Huang CN; Hsu TC; Chou HH; Tsay GJ
    J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
    Izumi M; Larsen PR
    J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease.
    O'Donnell J; Trokoudes K; Silverberg J; Row V; Volpé R
    J Clin Endocrinol Metab; 1978 May; 46(5):770-7. PubMed ID: 233633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
    Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
    J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic distress syndrome in patients with Graves' disease].
    Scheffer C; Heckmann C; Mijic T; Rudorff KH
    Med Klin (Munich); 2004 Oct; 99(10):578-84. PubMed ID: 15490073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life events, daily stresses and coping in patients with Graves' disease.
    Kung AW
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):303-8. PubMed ID: 7758236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous occurrence of subacute thyroiditis and Graves' disease.
    Hoang TD; Mai VQ; Clyde PW; Shakir MK
    Thyroid; 2011 Dec; 21(12):1397-400. PubMed ID: 22136271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.